Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
- PMID: 29046940
- PMCID: PMC5886993
- DOI: 10.1007/s00428-017-2240-x
Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
Abstract
Gastric cancer is traditionally divided into intestinal and diffuse histological subtypes, but recent molecular analyses have led to novel classification proposals based on genomic alterations. While the intestinal- and diffuse-type tumours are distinguishable from each other at the molecular level, intestinal-type tumours have more diverse molecular profile. The technology required for comprehensive molecular analysis is expensive and not applicable for routine clinical diagnostics. In this study, we have used immunohistochemistry and in situ hybridisation in molecular classification of gastric adenocarcinomas with an emphasis on the intestinal subtype. A tissue microarray consisting of 244 gastric adenocarcinomas was constructed, and the tumours were divided into four subgroups based on the presence of Epstein-Barr virus, TP53 aberrations and microsatellite instability. The intestinal- and diffuse-type tumours were separately examined. The distribution of EGFR and HER2 gene amplifications was studied in the intestinal-type tumours. Epstein-Barr virus positive intestinal-type tumours were more common in male patients (p = 0.035) and most often found in the gastric corpus (p = 0.011). The majority of the intestinal-type tumours with TP53 aberrations were proximally located (p = 0.010). All tumours with microsatellite instability showed intestinal-type histology (p = 0.017) and were associated with increased overall survival both in the univariate (p = 0.040) and multivariate analysis (p = 0.015). In conclusion, this study shows that gastric adenocarcinomas can be classified into biologically and clinically different subgroups by using a simple method also applicable for clinical diagnostics.
Keywords: Gastric cancer; Immunohistochemistry; In situ hybridisation; Molecular classification.
Conflict of interest statement
Conflict of interest
AÅ, ML, RR, JS and OC are inventors in a patent related to this work: US 20110217296 A1 Method for selecting patients for treatment with an EGFR inhibitor. All remaining authors declare that they have no conflict of interest.
Figures

Similar articles
-
Gastric cancer molecular classification based on immunohistochemistry and in-situ hybridisation and mortality.Histopathology. 2024 Aug;85(2):327-337. doi: 10.1111/his.15207. Epub 2024 May 7. Histopathology. 2024. PMID: 38715404
-
High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications.Am J Surg Pathol. 2017 Jan;41(1):106-115. doi: 10.1097/PAS.0000000000000756. Am J Surg Pathol. 2017. PMID: 27819872
-
EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus.BMC Cancer. 2016 Jul 7;16:406. doi: 10.1186/s12885-016-2456-1. BMC Cancer. 2016. PMID: 27387915 Free PMC article.
-
[Gastric tumors and tumor precursors].Pathologe. 2017 Mar;38(2):75-86. doi: 10.1007/s00292-016-0259-4. Pathologe. 2017. PMID: 28084526 Review. German.
-
Time to Classify Tumours of the Stomach and the Kidneys According to Cell of Origin.Int J Mol Sci. 2021 Dec 13;22(24):13386. doi: 10.3390/ijms222413386. Int J Mol Sci. 2021. PMID: 34948181 Free PMC article. Review.
Cited by
-
FHOD1 and FMNL1 formin proteins in intestinal gastric cancer: correlation with tumor-infiltrating T lymphocytes and molecular subtypes.Gastric Cancer. 2021 Nov;24(6):1254-1263. doi: 10.1007/s10120-021-01203-7. Epub 2021 Jun 11. Gastric Cancer. 2021. PMID: 34115237 Free PMC article.
-
Investigating the relationship between Epstein-Barr virus infection and gastric cancer: A systematic review and meta-analysis.Health Sci Rep. 2024 Mar 18;7(3):e1976. doi: 10.1002/hsr2.1976. eCollection 2024 Mar. Health Sci Rep. 2024. PMID: 38505684 Free PMC article. Review.
-
The prognostic role of fatty acid metabolism-related genes in patients with gastric cancer.Transl Cancer Res. 2022 Oct;11(10):3593-3609. doi: 10.21037/tcr-22-761. Transl Cancer Res. 2022. PMID: 36388036 Free PMC article.
-
Clinical Implementation of Precision Medicine in Gastric Cancer.J Gastric Cancer. 2019 Sep;19(3):235-253. doi: 10.5230/jgc.2019.19.e25. Epub 2019 Aug 12. J Gastric Cancer. 2019. PMID: 31598369 Free PMC article. Review.
-
Prognostic and immune infiltration significance of ARID1A in TCGA molecular subtypes of gastric adenocarcinoma.Cancer Med. 2023 Aug;12(16):16716-16733. doi: 10.1002/cam4.6294. Epub 2023 Jun 27. Cancer Med. 2023. PMID: 37366273 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon, International Agency for Research on Cancer http://globocan.iarc.fr. Accessed on 23 April 2017
-
- Cristescu R, Nebozhyn M, Kim K, Ting J, Wong S, Liu J, Yue Y, Wang J, Yu K, Ye X, Do I, Liu S, Gong L, Fu J, Jin J, Choi M, Sohn T, Lee J, Bae J, Kim S, Park S, Sohn I, Jung S, Tan P, Chen R, Hardwick J, Kang W, Ayers M, Hongyue D, Reinhard C, Loboda A, Aggarwal A. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21:449–456. doi: 10.1038/nm.3850. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous